Ophthalmology Times Europe

ADVERTISEMENT

SEARCH
  • home
  • about us
  • contact us
  • subscribe
  • media kit request
 

CATARACT

GLAUCOMA

REFRACTIVE

RETINA

ADVERTISEMENT

Previous StoryPlay / PauseNext Story
Latest retina news
Gene genie for AMD and RP?
February 12, 2010
Retinitis pigmentosa and AMD may be the beneficiaries of a new tool for gene therapy that significantly increases gene delivery to cells in the retina.
New retinal navigation system gains approval
November 11, 2009
The NAVILAS laser system, as reported on in the OTE Digest back in May this year ( What is Retinal Navigation? ) has been given FDA approval.
Two Phase III Lucentis studies show promise for RVO
October 14, 2009
Two Phase III studies of Lucentis (ranibizumab injection) in macular oedema due to retinal vein occlusion (RVO), have shown, on average, patients given either of two doses of Lucentis had a clinically and statistically significant improvement in vision as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity (BCVA) at six months compared to patients receiving sham injections. Results from both trials were presented at the Retina Congress 2009 meeting.
Cataract surgery in patients with pre-existing AMD: Risks and Benefits
September 15, 2009
Cataract surgery in patients with pre-existing AMD: Risks and Benefits
A review of the role and efficacy of anti-VEGF therapy in macular disease
September 15, 2009
A review of the role and efficacy of anti-VEGF therapy in macular disease
Retina articles
HEATAM Meetings 1,2 and 3
Professor David Wong reports on the third Heavy Tamponade meeting in Amsterdam and explains the background from the first and second events
Diabetic retinopathy: A growing concern in an ageing population
Diabetic retinopathy is a rising threat as the diabetic population increases
Using imaging to monitor retinal tissue response
Retinal tissue response after PASCAL laser photocoagulation
Proper supplement use advised for people with, or at risk of, AMD
The Ophthalmology Times Group talked to an optometrist practice about their experience with ocular nutraceuticals
DME responds to ranibizumab
Diabetic macular oedema responds to treatment with ranibizumab according to the results of the RESOLVE study.
Eye spy
Newsletter sign-up
Survey
What's your view of online learning/education for ophthalmology?
It would help me do my job better
Europe is well served
Europe is poorly served
Needs to be nationally orientated
Needs to be European orientated
Would never use
It would help me do my job better
100%
Europe is well served
0%
Europe is poorly served
0%
Needs to be nationally orientated
0%
Needs to be European orientated
0%
Would never use
0%
View Results
Thank you for voting
Call for papers

Click here to discover how you can have your say

ADVERTISEMENT

Click here